Join Dr. Michael Koren, CEO and Executive Director of MedEvidence, to explore how education and transparency can reshape the public’s understanding of clinical research. Dr. Koren shares his passion for putting patient welfare first and highlights how Med Evidence empowers individuals to make informed decisions about participating in trials. He discusses the importance of building trust, breaking down misconceptions, and helping communities see research as a valuable care option. Tune in to d...
All content for SCRS Talks is the property of Society for Clinical Research Sites and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Michael Koren, CEO and Executive Director of MedEvidence, to explore how education and transparency can reshape the public’s understanding of clinical research. Dr. Koren shares his passion for putting patient welfare first and highlights how Med Evidence empowers individuals to make informed decisions about participating in trials. He discusses the importance of building trust, breaking down misconceptions, and helping communities see research as a valuable care option. Tune in to d...
A powerful new partnership is transforming clinical trial budgeting. Join Medidata’s Tina Mincher and NIHR's Laura Bousfield as they dive into the evolution of the UK’s Interactive Costing Tool (iCT) and its integration into Medidata’s Grant Manager platform—unlocking new levels of standardization, transparency, and efficiency. With growing international interest, they discuss global collaborations like the Global Costing Task Force and how this initiative is setting the stage for data-d...
SCRS Talks
Join Dr. Michael Koren, CEO and Executive Director of MedEvidence, to explore how education and transparency can reshape the public’s understanding of clinical research. Dr. Koren shares his passion for putting patient welfare first and highlights how Med Evidence empowers individuals to make informed decisions about participating in trials. He discusses the importance of building trust, breaking down misconceptions, and helping communities see research as a valuable care option. Tune in to d...
